Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science Kigali, Rwanda July 13-17 Back

Is long-acting injectable antiretroviral therapy safe in countries with high hepatitis B prevalence?: insights from the IMPALA study ?       Ubaldo Bahemuka